NYSE:ELV Elevance Health (ELV) Stock Price, News & Analysis $404.12 +4.03 (+1.01%) Closing price 03:58 PM EasternExtended Trading$404.32 +0.20 (+0.05%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Elevance Health Stock (NYSE:ELV) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Elevance Health alerts:Sign Up Key Stats Today's Range$399.98▼$410.5450-Day Range$375.44▼$424.7852-Week Range$274.84▼$436.24Volume904,672 shsAverage Volume1.23 million shsMarket Capitalization$87.64 billionP/E Ratio17.96Dividend Yield1.70%Price Target$441.48Consensus RatingModerate Buy Company Overview Elevance Health, Inc. (NYSE: ELV) is a health benefits and services company that provides health insurance, managed care and related healthcare solutions in the United States. Its offerings serve individuals, employers, government-sponsored programs and other organizations across commercial, Medicare and Medicaid markets. The company operates a portfolio of health plans, including Blue Cross Blue Shield-affiliated plans in several states, as well as government-focused plans marketed under brands such as Wellpoint. Through its Carelon businesses, Elevance Health also provides pharmacy services, behavioral health support, care delivery, healthcare analytics and other solutions intended to help coordinate and manage patient care. Elevance Health was formerly known as Anthem, Inc. and adopted its current name in 2022 to reflect the company’s broader healthcare strategy beyond traditional health insurance. The company is led by President and Chief Executive Officer Gail K. Boudreaux and primarily serves customers and members throughout the United States.AI Generated. May Contain Errors. Read More Elevance Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks85th Percentile Overall ScoreELV MarketRank™: Elevance Health scored higher than 85% of companies evaluated by MarketBeat, and ranked 40th out of 884 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.1 / 5Analyst RatingModerate Buy Consensus RatingElevance Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.65, and is based on no strong buy ratings, 15 buy ratings, 8 hold ratings, and no sell ratings.Upside/DownsideThe consensus price target for Elevance Health is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageElevance Health has been the subject of 10 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Elevance Health's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth8.23% Earnings GrowthEarnings for Elevance Health are expected to grow by 8.23% in the coming year, from $27.21 to $29.45 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Elevance Health is 17.96, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.59.Price to Earnings Ratio vs. SectorThe P/E ratio of Elevance Health is 17.96, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.55.Price to Earnings Growth RatioElevance Health has a PEG Ratio of 2.08. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioElevance Health has a P/B Ratio of 2.04. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Elevance Health's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.47% of the float of Elevance Health has been sold short.Short Interest Ratio / Days to CoverElevance Health has a short interest ratio ("days to cover") of 4.21.Change versus previous monthShort interest in Elevance Health has recently decreased by 2.74%, indicating that investor sentiment is improving. Dividend4.2 / 5Dividend StrengthStrong Dividend YieldElevance Health pays a meaningful dividend of 1.72%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthElevance Health has been increasing its dividend for 14 years.Dividend CoverageThe dividend payout ratio of Elevance Health is 30.58%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Elevance Health will have a dividend payout ratio of 23.36% next year. This indicates that Elevance Health will be able to sustain or increase its dividend.Read more about Elevance Health's dividend. News and Social Media2.1 / 5News Sentiment0.40 News SentimentElevance Health has a news sentiment score of 0.40. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 8 news articles for Elevance Health this week, compared to 8 articles on an average week.Search Interest14 people have searched for ELV on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat FollowsOnly 7 people have added Elevance Health to their MarketBeat watchlist in the last 30 days. This is a decrease of -36% compared to the previous 30 days. Company Ownership0.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Elevance Health insiders have not sold or bought any company stock.Percentage Held by Insiders0.34% of the stock of Elevance Health is held by insiders.Percentage Held by Institutions89.24% of the stock of Elevance Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Elevance Health's insider trading history. Receive ELV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Elevance Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ELV Stock News HeadlinesElevance Health, Inc. (NYSE:ELV) Receives Average Recommendation of "Moderate Buy" from BrokeragesOctober 6 at 2:28 AM | americanbankingnews.comElevance Health consensus price target increased by 21.82% to MX$8,567.84October 5 at 8:53 AM | msn.comIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially the reasons why we’re bombing the country.October 7 at 1:00 AM | Banyan Hill Publishing (Ad)Elevance Health to Hold Conference Call and Webcast to Discuss Third Quarter 2026 Results on October 21, 2026October 5 at 8:53 AM | marketscreener.comM111 (NASDAQ:YI) versus Elevance Health (NYSE:ELV) Financial ReviewOctober 5 at 5:28 AM | americanbankingnews.comElevance Health (ELV): Conviction Pays Off as Underwriting Disciplines Stabilize MarginsOctober 1, 2026 | insidermonkey.comElevance Health’s Affiliated 2027 Medicare Advantage Plans Advance Stability, Choice and More Coordinated SupportOctober 1, 2026 | finance.yahoo.comElevance Health's quarterly earnings preview: What you need to knowSeptember 30, 2026 | msn.comSee More Headlines ELV Stock Analysis - Frequently Asked Questions How have ELV shares performed this year? Elevance Health's stock was trading at $350.59 at the start of the year. Since then, ELV shares have increased by 15.3% and is now trading at $404.1220. How were Elevance Health's earnings last quarter? Elevance Health, Inc. (NYSE:ELV) announced its quarterly earnings data on Wednesday, July, 15th. The company reported $7.45 earnings per share for the quarter, beating the consensus estimate of $6.21 by $1.24. The business's revenue for the quarter was up .8% on a year-over-year basis. Read the conference call transcript. Does Elevance Health have any subsidiaries? Elevance Health subsidiaries include Beacon Health Options, Aspire Healthcare Corp, America’s 1st Choice, HealthSun Health Plans, Simply Healthcare Holdings, Amerigroup, 1-800 Contacts, and more. Who are Elevance Health's major shareholders? Top institutional investors of Elevance Health include Rockland Trust Co. (0.03%), Benedict Financial Advisors Inc., CX Institutional and Coastline Trust Co. Insiders that own company stock include Gail Boudreaux, Felicia F Norwood, Robert L Dixon Jr, Charles Morgan Kendrick Jr, Ramiro G Peru, Susan D Devore and Ronald W Penczek. View institutional ownership trends. How do I buy shares of Elevance Health? Shares of ELV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Elevance Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Elevance Health investors own include NVIDIA (NVDA), Chevron (CVX), Meta Platforms (META), Advanced Micro Devices (AMD), Bristol Myers Squibb (BMY), Netflix (NFLX) and JPMorgan Chase & Co. (JPM). Company Calendar Last Earnings7/15/2026Record date for 9/25 Dividend9/10/2026Ex-Dividend for 9/25 Dividend9/10/2026Dividend Payable9/25/2026Today10/07/2026Next Earnings (Estimated)10/21/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (5m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 ELV's financial health is in the Green zone, according to TradeSmith. ELV has been in this zone for over 5 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryManaged Healthcare Current SymbolNYSE:ELV CIK1156039 Webwww.elevancehealth.com Phone(800) 331-1476Fax317-488-6275Employees97,100Year Founded1944Price Target and Rating Average Price Target for Elevance Health$441.48 High Price Target$498.00 Low Price Target$360.00 Potential Upside/Downside+9.2%Consensus RatingModerate Buy Rating Score (0-4)2.65 Research Coverage23 Analysts Profitability EPS (Trailing Twelve Months)$22.50 Trailing P/E Ratio17.96 Forward P/E Ratio14.85 P/E Growth2.08Net Income$5.66 billion Net Margins2.47% Pretax Margin2.91% Return on Equity14.64% Return on Assets5.22% Debt Debt-to-Equity Ratio0.68 Current Ratio1.52 Quick Ratio1.52 Sales & Book Value Annual Sales$199.13 billion Price / Sales0.44 Cash Flow$37.95 per share Price / Cash Flow10.65 Book Value$198.10 per share Price / Book2.04Miscellaneous Outstanding Shares216,870,000Free Float216,132,000Market Cap$87.64 billion OptionableOptionable Beta0.70 Social Links The Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free Report This page (NYSE:ELV) was last updated on 10/7/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elevance Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Elevance Health With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
